Clinical Trials Logo

Survival clinical trials

View clinical trials related to Survival.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05568576 Completed - Survival Clinical Trials

Metabolic Syndrome and Long-term Survival Following Liver Resection

Start date: January 1, 2015
Phase:
Study type: Observational

Although hepatitis C virus (HCV) infection remains one of the main causes of hepatocellular carcinoma (HCC) worldwide, metabolic syndrome, with its increase in prevalence, has become an important and significant risk factor for HCC

NCT ID: NCT05406089 Completed - Clinical trials for Hepatocellular Carcinoma

Effects of Antiviral Therapy on Patients With HBV-related HCC

Start date: January 1, 2016
Phase:
Study type: Observational

Based on the follow-up data of patients who underwent hepatectomy for HBV-related HCC at the First Affiliated Hospital of Xi'an Jiaotong University. patients who met the enrollment criteria were screened for tumor recurrence and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

NCT ID: NCT05355662 Completed - Clinical trials for Hepatocellular Carcinoma

Prognosis Analysis of Elderly Donor Liver in Liver Transplantation

Start date: January 1, 2015
Phase:
Study type: Observational

Based on the follow-up data of elderly donation after cardiac death(DCD) donor liver transplant recipients from the CLTR, a database and official website for national data gathering. patients who met the enrollment criteria were screened for postoperative complications and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

NCT ID: NCT05114369 Completed - Survival Clinical Trials

Does Timing of Completion Radical Cholecystectomy Determine the Survival in Incidental Carcinoma Gallbladder

IGBC
Start date: January 1, 2009
Phase:
Study type: Observational

Various factors determine the long term survival in this non-uniform cohort of incidental gallbladder cancer. Timing of re-intervention is suggested to play an important role in the outcome. Few centers are proponents of early surgery in order to prevent dissemination, while others have suggested an intentional delay of 3 months to filter out cases with aggressive pathology. In the present study, investigators intend to evaluate the factors affecting survival in incidental Gallbladder Cancer (IGBC) with special reference to timing of re-intervention.

NCT ID: NCT04956562 Completed - Intensive Care Unit Clinical Trials

Effect of Sinovac on Survival in Intensive Care Unit

Start date: April 1, 2021
Phase:
Study type: Observational

Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience

NCT ID: NCT04663191 Completed - Lung Cancer Clinical Trials

Intraoperative Conversion During Video-assisted Thoracoscopy Resection for Lung Cancer Does Not Alter Survival

ICVATR
Start date: January 2, 2020
Phase:
Study type: Observational

Anatomical resection with systematic lymph-node dissection is currently the standard of care for the treatment of early stage non-small cell lung cancer. The use of minimally invasive approaches has increased greatly over the last two decades [either video-assisted thoracoscopic surgery (VATS) or robotic-assisted thoracoscopic surgery (RATS)], as they provide the patient with better outcomes than open thoracotomy. Minimally invasive VATS lobectomy for a standard case is generally a straightforward procedure for a well-trained surgical team, although concomitant preoperative pathologies or intraoperative findings/adverse events may result in technical difficulties, leading to intraoperative conversion, commonly by thoracotomy. The investigators aimed to assess long-term outcomes in a consecutive cohort of patients treated by anatomical pulmonary resection either using VATS, VATS requiring intraoperative conversion to thoracotomy, or upfront open thoracotomy for lung-cancer surgery.

NCT ID: NCT04546243 Completed - Pulmonary Disease Clinical Trials

Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective Study

Start date: January 1, 2020
Phase:
Study type: Observational

According to EURAMOS-1, 17% of osteosarcoma patients were considered to have metastases at diagnosis. In this selected cohort, the reported 5-year EFS from diagnosis of 28% compares well to previous results reported from unselected cohorts of patients with only lung metastases. Resection of pulmonary metastases from osteosarcoma is a treatment option which has been shown to correlate with survival benefit and cure in select individuals. These patients are best addressed in a multidisciplinary fashion, with the involvement of a thoracic surgeon with experience in pulmonary metastasectomy. At the same time, the goal of surgical resection of pulmonary metastases from osteosarcoma is to render the patient completely disease free. "Tumor debulking" or "cytoreductive surgery" with incomplete resection has not demonstrated any survival benefit for patients with pulmonary metastases. Thus open thoracotomy is more preferred than VATS. However over the last decade in China, thoracotomy has not been adopted generally. More patients had chosen VATS or even hypo-fractionation radiotherapy, such as gamma knife, cyber knife and so on as a local treatment method. This study aims to investigate the survival of consecutive patients who had achieved a first complete surgical remission (CR) during combined-modality therapy on neoadjuvant or adjuvant PKUPH-OS protocol so as to discuss reasonable local therapy for resectable pulmonary osteosarcoma metastatic lesions.

NCT ID: NCT04519450 Completed - Clinical trials for Mechanical Ventilation

Ultrasound of Accessory Respiratory Muscles

Start date: March 3, 2020
Phase:
Study type: Observational

The aim of this study is to compare the diameter of accessory respiratory muscles in patients with respiratory diseases and patients without such diseases, and to determine whether there is a connection between the ultrasound-measured thickness of accessory respiratory muscles and time of mechanical ventilation, as well as whether there is a the connection between the measured thickness and the treatment outcome of patients in the Intensive Care Unit (ICU).

NCT ID: NCT04477720 Completed - Survival Clinical Trials

Retrospective Analysis of De-identified Deceased HCC Patients

Start date: June 1995
Phase:
Study type: Observational

De-identified deceased HCC patients who were not surgical candidates were evaluated for their clinical baseline characteristics associated with their survival. Baselines included tumor markers, blood counts and liver function tests and CAT-scan based tumor size and numbers and presence of portal vein thrombosis.

NCT ID: NCT04449796 Completed - Survival Clinical Trials

Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients

Start date: June 1, 2018
Phase:
Study type: Observational [Patient Registry]

Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of body composition, changes with the physical condition of patients and is associated with survival in several disease states and during ICU admission. Aim of the study is to explore the predictive value of the phase angle for long term ICU outcome.